Funded Grants

Close to 600,000 Canadians currently live with Alzheimer’s disease and related dementias, but effective therapies are limited and focus on symptom management rather than a cure.

Alzheimer’s disease progresses over time due to the spreading of aggregates of tau protein and amyloid protein from unaffected to affected regions of the brain.

Amnestic mild cognitive impairment (aMCI) is viewed as a precursor to Alzheimer’s Disease (AD) for which there are no effective treatments.

Alzheimer’s disease is the most common form of dementia.

Individuals with or at increased risk of Alzheimer’s disease (AD) have an altered community of microbes(microbiome) within the intestinal tract.

The BRAID Hub (Brain health Resources And Integrated Diversity Hub) addresses critical gaps in Canada’s dementia care system.

Alzheimer’s disease (AD) is the most common form of dementia and 7th leading cause of death in North-America.

Alzheimer’s Disease (AD) is characterized by memory decline and neuronal pathology, including amyloid β (Aβ)plaques and oxidative stress.

Infections like pneumonia can speed up dementia. Vaccinations can prevent infections but don’t always work in older adults.

Everyday activities such as cooking often become difficult for people living with dementia.